IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 22 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $95,000 | +1.1% | 25,000 | 0.0% | 0.05% | -2.1% |
| Q2 2016 | $94,000 | -5.1% | 25,000 | 0.0% | 0.05% | -5.9% |
| Q1 2016 | $99,000 | -42.8% | 25,000 | 0.0% | 0.05% | -44.6% |
| Q4 2015 | $173,000 | +7.5% | 25,000 | 0.0% | 0.09% | +12.2% |
| Q3 2015 | $161,000 | -20.7% | 25,000 | 0.0% | 0.08% | -12.8% |
| Q2 2015 | $203,000 | +1.5% | 25,000 | 0.0% | 0.09% | +5.6% |
| Q1 2015 | $200,000 | +6.4% | 25,000 | 0.0% | 0.09% | -48.6% |
| Q4 2014 | $188,000 | +1.1% | 25,000 | 0.0% | 0.17% | +3.0% |
| Q3 2014 | $186,000 | +6.9% | 25,000 | 0.0% | 0.17% | +20.0% |
| Q2 2014 | $174,000 | +3.6% | 25,000 | 0.0% | 0.14% | +11.1% |
| Q1 2014 | $168,000 | – | 25,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,205,000 | $8,351,000 | 3.49% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 622,744 | $4,316,000 | 1.61% |
| MARATHON CAPITAL MANAGEMENT | 25,000 | $173,000 | 0.09% |
| Granite Investment Partners, LLC | 125,251 | $868,000 | 0.08% |
| REGIONS FINANCIAL CORP | 30,500 | $211,000 | 0.00% |
| CIBC Private Wealth Group, LLC | 29,297 | $203,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 576 | $4,000 | 0.00% |
| Formidable Asset Management, LLC | 300 | $2,000 | 0.00% |
| BlackRock Investment Management, LLC | 1,211 | $8,000 | 0.00% |
| CITIGROUP INC | 25 | $0 | 0.00% |